that was almost certainy a predictive text error on Kev's device... daily aspirin tanscribed to baby adaption .. a bit like cancer cells mutating ! I have to say it is one of the reasons I switch off the "aid" on my tablet! It did make me smile on a sunny Sunday morning though.
A daiy dose of aspirin has been used in treating heart disease and stroke patients or those at risk of heart disease for many years now. It is thought to work by slightly thinning the blood.
In the cancer research field there has been some evidence to show that less sticky blood makes it more difficult for cancer cells to adhere to blood vessel walls. This may reduce their ability to invade the vascular system and therefore gain a free transport system to take them to the next destination (Mets or lymph node invasion). Given time the little horrors can actually build their own blood vessels so that theory may not hold good forever.
Also aspirin contains a basic natural ingredient (willow bark or meadowsweet) that is slightly toxic so it might help to kill off cancerous cells that have recently had their DNA messed up by RT. A kind of mini and less side effect strewn chemo.??
It is such a cheap drug so there is not much to lose trialling it and a lot to be gained if it works.
As a word of caution anyone with a history of bleeding disorders, ulcers, or already on drugs like warfarin do not start taking aspirin without consulting your medical practitioner.
The EN2 test you mentioned has been on the cards for quite a while but the initial study was done on such a small number of patients out of Surrey University. So it had to be tested on a much wider audience, It is proably going to be used to augment the PSA test not replace it. The PSA test will still indicate the possible presence of prostate cancer, the EN2 test is aiming to confirm the presence and possibly the size of a tumour (the higher the EN2 the bigger the tumour I guess) reading between the lines I think the EN2 test could also be used for detection of other cancers.
I think that will give GPs and other clinicians a better tool to treat (or not as the case may be) low grade very slow growing PCa. without the need for biopsies, scans etc. For patients they are not sure about or those who clearly have a much bigger problem all the traditional tests would still need to be done.
That leaves a bit of a problem possibly for many men, who knowing they have cancer no matter how small or currently inactive, just want rid of it out of their body right here and right now.
It is all positive steps forward though which is great news.
best wishes as always